| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2837112 | Cardiovascular Revascularization Medicine | 2011 | 6 Pages |
Abstract
The UC is an independent predictor of long-term outcomes in AMI patients compared to the STC. Type 2 AMI has less than half the risk of MACE as Type 1 AMI. Future studies should report outcomes of AMI patients according to the UC types.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Manuel A. Gonzalez, Dana J. Eilen, Rana A. Marzouq, Christopher P. Porterfield, Surovi Hazarika, Summiyah Nasir, Amit A. Patel, Karyll De J. Gonzalez, Michael B. Burris, Mayelin Prieto-Gonzalez, John D. Rose, Wayne E. Cascio,